<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: At the beginning the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> syndrome was associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>But since 1988 it has become a sole entity </plain></SENT>
<SENT sid="2" pm="."><plain>Its current definition is based on the criteria established in 1999 by Sapporo and consists of associating the clinical criteria of <z:mp ids='MP_0005048'>thrombosis</z:mp> of arteries or peripheral veins and of <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage of pregnancy</z:e> with the biological criteria </plain></SENT>
<SENT sid="3" pm="."><plain>Either anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> must be present </plain></SENT>
<SENT sid="4" pm="."><plain>Anti-<z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi> antibodies are not included in the Sapporo criteria </plain></SENT>
<SENT sid="5" pm="."><plain>CASE REPORT: A non smoking, 43 year-old man showed a clinical manifestation of livedo on the thighs, and left knee and foot, associated with a rapidly extending cutaneous <z:mp ids='MP_0001651'>necrosis</z:mp> on the left toes </plain></SENT>
<SENT sid="6" pm="."><plain>One year earlier his right leg was amputated up to half of the calf following distal <z:hpo ids='HP_0100758'>gangrene</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:hpo ids='HP_0100758'>gangrene</z:hpo> was consecutive to a stent implantation after a significant stenosis of the right superficial femoral artery </plain></SENT>
<SENT sid="8" pm="."><plain>The etiological investigations revealed neither thrombophily nor <z:e sem="disease" ids="C0149649" disease_type="Disease or Syndrome" abbrv="">cholesterol embolism</z:e> nor <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>No sign of underlying <z:hpo ids='HP_0002664'>neoplasia</z:hpo> could be found </plain></SENT>
<SENT sid="10" pm="."><plain>These clinical symptoms as well as the anamnesis were strongly suggestive of an <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> syndrome </plain></SENT>
<SENT sid="11" pm="."><plain>The immunological dosages revealed isolated positive anti-<z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi> antibodies, persistent six weeks later </plain></SENT>
<SENT sid="12" pm="."><plain>DISCUSSION: Several cases of clinical manifestations of the <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> syndrome have been described, without any anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, but with presence of anti-<z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi> antibodies </plain></SENT>
<SENT sid="13" pm="."><plain>In cases of these strong evocative symptoms but no evidence of the classical biological Sapporo criteria, these antibodies should be systematically searched for </plain></SENT>
</text></document>